THE LEADING LIGHT IN CANCER TREATMENT Trademark
Trademark Overview
On Monday, April 24, 1995, a trademark application was filed for THE LEADING LIGHT IN CANCER TREATMENT with the United States Patent and Trademark Office. The USPTO has given the THE LEADING LIGHT IN CANCER TREATMENT trademark a serial number of 74665344. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Thursday, June 6, 1996. This trademark is owned by Laserscope. The THE LEADING LIGHT IN CANCER TREATMENT trademark is filed in the Medical Instrument Products category with the following description:
cancer treatment methods utilizing photodynamic therapy processes and equipment
General Information
Serial Number | 74665344 |
Word Mark | THE LEADING LIGHT IN CANCER TREATMENT |
Filing Date | Monday, April 24, 1995 |
Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
Status Date | Thursday, June 6, 1996 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 1000 - Typeset: Word(s) / letter(s) / number(s) |
Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
Goods and Services | cancer treatment methods utilizing photodynamic therapy processes and equipment |
Classification Information
International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
US Class Codes | 026, 039, 044 |
Class Status Code | 8 - Abandoned |
Class Status Date | Wednesday, August 4, 1999 |
Primary Code | 010 |
First Use Anywhere Date | Friday, March 24, 1995 |
First Use In Commerce Date | Friday, March 24, 1995 |
Trademark Owner History
Party Name | Laserscope |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | San Jose, CA 95134 |
Trademark Events
Event Date | Event Description |
Thursday, June 6, 1996 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
Monday, September 25, 1995 | NON-FINAL ACTION MAILED |
Monday, September 11, 1995 | ASSIGNED TO EXAMINER |